Every cancer is unique. We profile each patient’s mutational fingerprint to define the right treatment strategy.READ MORE
Hiding in Plain Sight
Neoantigens are ideal, untapped targets against cancer.READ MORE
Advancing in the Clinic
We are a leader in the field of neoantigen-targeted therapies.READ MORE
Our scientific founders
The leading cancer researchers who founded Neon Therapeutics had a bold vision: To develop a powerful new class of drugs that direct the immune system towards unique targets on tumor cells, called neoantigens. Watch our founders explain this approach.